Lanzhou Institute of Biological Products Co., Ltd

Quick facts

Phase 3 pipeline

• Botulinum Toxin Type A for Injection · Neurology; Dermatology; Aesthetics
  Botulinum toxin type A blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Lanzhou Institute of Biological Products Co., Ltd portfolio CI brief
• Lanzhou Institute of Biological Products Co., Ltd pipeline updates RSS